| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1120 | 2019 |
| Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002) SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ... Journal of Clinical Oncology 39 (9), 956, 2021 | 243 | 2021 |
| Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer CM Anderson, CM Lee, DP Saunders, A Curtis, N Dunlap, C Nangia, ... Journal of Clinical Oncology 37 (34), 3256, 2019 | 93 | 2019 |
| Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data A Blakaj, M Bonomi, ME Gamez, DM Blakaj Oral oncology 95, 29-34, 2019 | 93 | 2019 |
| NRG-HN002: a randomized phase II trial for patients with p16-positive, non-smoking-associated, locoregionally advanced oropharyngeal cancer SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, ... International Journal of Radiation Oncology, Biology, Physics 105 (3), 684-685, 2019 | 82 | 2019 |
| Time to surgery and survival in head and neck cancer CJ Rygalski, S Zhao, A Eskander, KY Zhan, EA Mroz, G Brock, ... Annals of surgical oncology 28, 877-885, 2021 | 80 | 2021 |
| Molecular dynamics and thermodynamics of protein− RNA interactions: Mutation of a conserved aromatic residue modifies stacking interactions and structural adaptation in the U1A … DM Blakaj, KJ McConnell, DL Beveridge, AM Baranger Journal of the American Chemical Society 123 (11), 2548-2551, 2001 | 68 | 2001 |
| Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen, R Thapa, M Mills, ... The Lancet 400 (10357), 1008-1019, 2022 | 55 | 2022 |
| Single-isocenter multitarget stereotactic radiosurgery is safe and effective in the treatment of multiple brain metastases JD Palmer, NT Sebastian, J Chu, D DiCostanzo, EH Bell, J Grecula, ... Advances in Radiation Oncology 5 (1), 70-76, 2020 | 51 | 2020 |
| Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study E Gez, S Cytron, RB Yosef, D London, BW Corn, S Alani, G Scarzello, ... Radiation Oncology 8, 1-7, 2013 | 51 | 2013 |
| Evolutionary and biophysical relationships among the papillomavirus E2 proteins DM Blakaj, N Fernandez-Fuentes, Z Chen, R Hegde, A Fiser, RD Burk, ... Frontiers in bioscience: a journal and virtual library 14, 900, 2009 | 45 | 2009 |
| Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies MR Bonomi, A Blakaj, D Blakaj Oral oncology 86, 301-306, 2018 | 37 | 2018 |
| A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma TN Teknos, J Grecula, A Agrawal, MO Old, E Ozer, R Carrau, S Kang, ... Investigational New Drugs 37, 702-710, 2019 | 35 | 2019 |
| Emerging concepts and novel strategies in radiation therapy for laryngeal cancer management ME Gamez, A Blakaj, W Zoller, M Bonomi, DM Blakaj Cancers 12 (6), 1651, 2020 | 31 | 2020 |
| Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell … RL Ferris, ML Gillison, J Harris, AD Colevas, LK Mell, C Kong, R Jordan, ... Journal of Clinical Oncology 36 (15_suppl), 6010-6010, 2018 | 30 | 2018 |
| Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck … NV Anayannis, NF Schlecht, M Ben-Dayan, RV Smith, TJ Belbin, TJ Ow, ... PloS one 13 (2), e0191581, 2018 | 30 | 2018 |
| LCL161, a SMAC-mimetic, preferentially radiosensitizes human papillomavirus–negative head and neck squamous cell carcinoma L Yang, B Kumar, C Shen, S Zhao, D Blakaj, T Li, M Romito, TN Teknos, ... Molecular cancer therapeutics 18 (6), 1025-1035, 2019 | 27 | 2019 |
| Decision making in advanced larynx cancer: an evidenced based review A Eskander, DM Blakaj, PT Dziegielewski Oral oncology 86, 195-199, 2018 | 27 | 2018 |
| Indirect readout of DNA sequence by papillomavirus E2 proteins depends upon net cation uptake DM Blakaj, C Kattamuri, S Khrapunov, RS Hegde, M Brenowitz Journal of molecular biology 358 (1), 224-240, 2006 | 26 | 2006 |
| 25-year follow-up of HIV-positive patients with benign lymphoepithelial cysts of the parotid glands: a retrospective review WF Mourad, R Young, R Kabarriti, DM Blakaj, RA Shourbaji, J Glanzman, ... Anticancer Research 33 (11), 4927-4932, 2013 | 23 | 2013 |
Joshua D. Palmer, MDAssociate Professor, The Department of Radiation Oncology, The James Cancer Hospital at OSUVerified email at osumc.edu
